Products Name |
Cat.No. |
Animal Type |
Disease Area |
Leptin inhibition, pancreatectomy/high fat diet-induced, in rat (Sprague Dawley)
|
AB14801 |
rat |
|
Lipopolysaccharide binding protein inhibition, ethanol-induced, in rat (Sprague Dawley)
|
AB14802 |
rat |
|
Lipoprotein associated phospholipase A2 (Lp-PLA2) inhibition, in fasted rat (Sprague Dawley)
|
AB14803 |
rat |
|
Liver cancer (hepatocellular carcinoma), diethylnitrosamine/2-acetylaminofluorene-induced, in rat (Sprague Dawley)
|
AB14804 |
rat |
Cancer,liver (hepatocellular carcinoma) |
Liver cancer (hepatocellular carcinoma), liver radiofrequency ablation-induced, in rat (Sprague Dawley)
|
AB14805 |
rat |
Cancer,liver (hepatocellular carcinoma) |
Liver cancer (hepatocellular carcinoma), N-nitrosodiethylamine/2-acetylaminofluorene/partial hepatectomy-induced, in rat (Sprague Dawley)
|
AB14806 |
rat |
Cancer,liver (hepatocellular carcinoma) |
Liver cancer (hepatocellular carcinoma), orthotopic allograft (AS30D)/laser-induced, in rat (Sprague Dawley)
|
AB14807 |
rat |
Cancer,liver (hepatocellular carcinoma) |
Liver cancer (hepatocellular carcinoma), orthotopic allograft (N1-S1)/laser-induced, in rat (Sprague Dawley)
|
AB14808 |
rat |
Cancer,liver (hepatocellular carcinoma) |
Liver cancer (hepatocellular carcinoma), syngeneic graft (N1-S1), in rat (Sprague Dawley)
|
AB14809 |
rat |
Cancer,liver (hepatocellular carcinoma) |
Liver cancer (hepatocellular carcinoma), xenograft (McARH7777), in rat (Sprague Dawley)
|
AB14810 |
rat |
Cancer,liver (hepatocellular carcinoma) |